v3.26.1
Financial Instruments
6 Months Ended
Jun. 30, 2026
Financial Instruments  
Financial Instruments

3. Financial Instruments

The following table shows the Company’s cash, cash equivalent and investments by significant investment category as of June 30, 2026:

As of June 30, 2026

  ​ ​ ​

Cash and Cash

Short-Term

Long-Term

  ​ ​ ​

Amortized Cost

Unrealized Gains

Unrealized Losses

Fair Value

Equivalents

Investments

Investments

Cash

$

$

$

$

$

13,434

$

$

Level 1:

 

Money market funds

117,303

U.S. Treasury securities

 

135,955

1,868

137,823

137,823

Level 2:

Government securities

14,910

(41)

14,869

4,958

9,911

Total

$

150,865

$

1,868

$

(41)

$

152,692

$

130,737

$

142,781

$

9,911

As of December 31, 2025

  ​ ​ ​

Cash and Cash

Short-Term

Long-Term

  ​ ​ ​

Amortized Cost

Unrealized Gains

Unrealized Losses

Fair Value

Equivalents

Investments

Investments

Cash

$

$

$

$

$

3,267

$

$

Level 1:

 

Money market funds

93,897

U.S. Treasury securities

 

199,497

1,129

200,626

200,626

Level 2:

Government securities

Total

$

199,497

$

1,129

$

$

200,626

$

97,164

$

200,626

$

As of June 30, 2026, accrued interest earned of $98 related to investments were included in prepaid expenses and other current assets on the condensed consolidated balance sheets. There was no allowance for expected credit losses on available-for-sale debt securities included as of June 30, 2026 as the unrealized losses were deemed to be temporary in nature.

The following table shows the fair value of the Company’s investments, by contractual maturity, as of June 30, 2026:

Due within 1 year

$

142,781

Due after 1 year through 5 years

 

9,911

Total fair value

$

152,692